CN104666512A - Traditional Chinese medicine for treating hypertension - Google Patents
Traditional Chinese medicine for treating hypertension Download PDFInfo
- Publication number
- CN104666512A CN104666512A CN201310642357.5A CN201310642357A CN104666512A CN 104666512 A CN104666512 A CN 104666512A CN 201310642357 A CN201310642357 A CN 201310642357A CN 104666512 A CN104666512 A CN 104666512A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- fructus
- herba
- artemisiae annuae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating hypertension, belonging to the technical field of traditional Chinese medicines. The invention provides a traditional Chinese medicine for treating hypertension, which can be used for inhibiting hypertension and has no toxic or side effects if being taken for a long term. The traditional Chinese medicine for treating hypertension is characterized by being prepared from 2-8 parts of sweet wormwood herbs, 2-8 parts of sophora fruits, 2-8 parts of fructus kochiae, 2-8 parts of cynomorium songaricum, 2-8 parts of sappanwood, 2-8 parts of acorn, 2-8 parts of pulvis aci, 2-8 parts of radix morindae officinalis and 2-8 parts of Chinese lutes.
Description
Technical field
The invention belongs to technical field of Chinese medicine, specifically, the present invention relates to one and treat hypertensive Chinese medicine.
Background technology
Hypertension is modal chronic disease, and be also the topmost risk factor of cardiovascular and cerebrovascular disease, apoplexy, myocardial infarction, heart failure and chronic kidney disease are its major complications.
Hypertension is modal chronic disease, and be also the topmost risk factor of cardiovascular and cerebrovascular disease, apoplexy, myocardial infarction, heart failure and chronic kidney disease are its major complications.Both domestic and externally facts have proved, hypertension is can the disease of prevention and corntrol, reduces the blood pressure level of hyperpietic, can obviously reduce apoplexy and the events of heart attack, significantly improve the life quality of patient, effectively reduce Disease Spectrum.The blood pressure level of hypertensive hazardness and patient mutually outside the Pass, also depend on the situation of other diseases of other cardiovascular risk factors simultaneous, target organ damage and merging.Therefore in hypertensive definition and classification, hypertensive diagnostic criteria is fixed on systolic pressure >=140mmHg and (or) diastolic pressure >=90mmHg, be divided into normally according to blood pressure level, outside High-normal blood pressure and 1,2,3 grade of hypertension, also carry out risk stratification according to risk factor, target organ damage and the other diseases that merges simultaneously simultaneously.
Prevalence of Hypertension increases with the age and raises; Women's prevalence before climacteric, a little less than male, but to raise rapidly, even higher than male after climacteric; High latitude cold district prevalence is higher than the warm area of low latitudes, and high altitude localities is higher than low altitude area; Relevant with dietary habit, salt and saturated fat are taken in higher, and mean blood pressure level and prevalence are also higher.Population of China hypertension is popular has two to compare outstanding feature: from south to the north, Prevalence of Hypertension is increasing trend; Between different nationalities, Prevalence of Hypertension also has some differences, the national prevalence of living in the north or highlands is higher, the national prevalence of living in south or non-highlands is then lower, this species diversity may be relevant with geographical environment, life style etc., not yet finds there is obvious genetic background difference between various nationalities.
Treating hypertensive main purpose is reduce cardiovascular morbidity and dead total danger to greatest extent, therefore require that doctor is treating hypertensive while, intervene the clinical disease that all reversibility cardiovascular risk factors of patient, target organ damage and merging exist.Be below 140/90mmHg for general hyperpietic's blood pressure lowering target, for the high risk patient such as complication with diabetes or nephropathy, blood pressure should take the circumstances into consideration to be down to more low-level in the tolerant situation of patient.
Summary of the invention
The present invention is exactly for above-mentioned technical problem, and providing one can have suppression hypertension, the hypertensive Chinese medicine for the treatment of of long-term use without side effects.
For realizing above-mentioned purpose of the present invention, the present invention adopts following technical scheme: the hypertensive Chinese medicine for the treatment of of the present invention, is characterized in that: be made up of Herba Artemisiae Annuae 2-8 part, Fructus Sophorae 2-8 part, Fructus Kochiae 2-8 part, Herba Cynomorii 2-8 part, Lignum Sappan 2-8 part, acorn nut 2-8 part, Pulvis Aci 2-8 part, bar halberd 2-8 part, Chinese lute 2-8 part.
Beneficial effect of the present invention: flavour of a drug of the present invention are few, and cost of drugs is cheap, is easy to configuration; And have no side effect, curative effect is good, cure speed soon, the phthisical object of radical cure can be reached.
The present invention is through clinical verification, and effective percentage reaches 80%, and cure rate reaches more than 75%.
Detailed description of the invention
The phthisical medicine for the treatment of of the present invention, is characterized in that: be made up of Herba Artemisiae Annuae 2-8 part, Fructus Sophorae 2-8 part, Fructus Kochiae 2-8 part, Herba Cynomorii 2-8 part, Lignum Sappan 2-8 part, acorn nut 2-8 part, Pulvis Aci 2-8 part, bar halberd 2-8 part, Chinese lute 2-8 part.
Embodiment 1: be made up of Herba Artemisiae Annuae 2 parts, the Fructus Sophorae 2 parts, the Fructus Kochiae 2 parts, Herba Cynomorii 2 parts, Lignum Sappan 2 parts, acorn nut 2 parts, Pulvis Aci 2 parts, bar halberd 2 parts, 2 parts, Chinese lute.
Embodiment 2: be made up of Herba Artemisiae Annuae 3 parts, the Fructus Sophorae 3 parts, the Fructus Kochiae 3 parts, Herba Cynomorii 3 parts, Lignum Sappan 3 parts, acorn nut 3 parts, Pulvis Aci 3 parts, bar halberd 3 parts, 3 parts, Chinese lute.
Embodiment 3: be made up of Herba Artemisiae Annuae 4 parts, the Fructus Sophorae 4 parts, the Fructus Kochiae 4 parts, Herba Cynomorii 4 parts, Lignum Sappan 4 parts, acorn nut 4 parts, Pulvis Aci 4 parts, bar halberd 4 parts, 4 parts, Chinese lute.
Embodiment 4: be made up of Herba Artemisiae Annuae 5 parts, the Fructus Sophorae 5 parts, the Fructus Kochiae 5 parts, Herba Cynomorii 5 parts, Lignum Sappan 5 parts, acorn nut 5 parts, Pulvis Aci 5 parts, bar halberd 5 parts, 5 parts, Chinese lute.
Embodiment 5: be made up of Herba Artemisiae Annuae 6 parts, the Fructus Sophorae 6 parts, the Fructus Kochiae 6 parts, Herba Cynomorii 6 parts, Lignum Sappan 6 parts, acorn nut 6 parts, Pulvis Aci 6 parts, bar halberd 6 parts, 6 parts, Chinese lute.
Embodiment 6: be made up of Herba Artemisiae Annuae 7 parts, the Fructus Sophorae 7 parts, the Fructus Kochiae 7 parts, Herba Cynomorii 7 parts, Lignum Sappan 7 parts, acorn nut 7 parts, Pulvis Aci 7 parts, bar halberd 7 parts, 7 parts, Chinese lute.
Embodiment 7: be made up of Herba Artemisiae Annuae 8 parts, the Fructus Sophorae 8 parts, the Fructus Kochiae 8 parts, Herba Cynomorii 8 parts, Lignum Sappan 8 parts, acorn nut 8 parts, Pulvis Aci 8 parts, bar halberd 8 parts, 8 parts, Chinese lute.
Embodiment 8: be made up of Herba Artemisiae Annuae 8 parts, the Fructus Sophorae 7 parts, the Fructus Kochiae 6 parts, Herba Cynomorii 5 parts, Lignum Sappan 4 parts, acorn nut 6 parts, Pulvis Aci 3 parts, bar halberd 5 parts, 2 parts, Chinese lute.
Embodiment 9: be made up of Herba Artemisiae Annuae 2 parts, the Fructus Sophorae 3 parts, the Fructus Kochiae 4 parts, Herba Cynomorii 5 parts, Lignum Sappan 6 parts, acorn nut 7 parts, Pulvis Aci 8 parts, bar halberd 7 parts, 7 parts, Chinese lute.
Case: patient age: 35 years old, use the embodiment of the present invention 1 compounding pharmaceutical, blood pressure can be down to normally by the same day, then use every day, and blood pressure can held stationary level always, and long-term taking is without any side effects.
Claims (10)
1. treat a hypertensive Chinese medicine, it is characterized in that: be made up of Herba Artemisiae Annuae 2-8 part, Fructus Sophorae 2-8 part, Fructus Kochiae 2-8 part, Herba Cynomorii 2-8 part, Lignum Sappan 2-8 part, acorn nut 2-8 part, Pulvis Aci 2-8 part, bar halberd 2-8 part, Chinese lute 2-8 part.
2. one according to claim 1 treats hypertensive Chinese medicine, it is characterized in that: be made up of Herba Artemisiae Annuae 2 parts, the Fructus Sophorae 2 parts, the Fructus Kochiae 2 parts, Herba Cynomorii 2 parts, Lignum Sappan 2 parts, acorn nut 2 parts, Pulvis Aci 2 parts, bar halberd 2 parts, 2 parts, Chinese lute.
3. one according to claim 1 treats hypertensive Chinese medicine, it is characterized in that: be made up of Herba Artemisiae Annuae 3 parts, the Fructus Sophorae 3 parts, the Fructus Kochiae 3 parts, Herba Cynomorii 3 parts, Lignum Sappan 3 parts, acorn nut 3 parts, Pulvis Aci 3 parts, bar halberd 3 parts, 3 parts, Chinese lute.
4. one according to claim 1 treats hypertensive Chinese medicine, it is characterized in that: be made up of Herba Artemisiae Annuae 4 parts, the Fructus Sophorae 4 parts, the Fructus Kochiae 4 parts, Herba Cynomorii 4 parts, Lignum Sappan 4 parts, acorn nut 4 parts, Pulvis Aci 4 parts, bar halberd 4 parts, 4 parts, Chinese lute.
5. one according to claim 1 treats hypertensive Chinese medicine, it is characterized in that: be made up of Herba Artemisiae Annuae 5 parts, the Fructus Sophorae 5 parts, the Fructus Kochiae 5 parts, Herba Cynomorii 5 parts, Lignum Sappan 5 parts, acorn nut 5 parts, Pulvis Aci 5 parts, bar halberd 5 parts, 5 parts, Chinese lute.
6. one according to claim 1 treats hypertensive Chinese medicine, it is characterized in that: be made up of Herba Artemisiae Annuae 6 parts, the Fructus Sophorae 6 parts, the Fructus Kochiae 6 parts, Herba Cynomorii 6 parts, Lignum Sappan 6 parts, acorn nut 6 parts, Pulvis Aci 6 parts, bar halberd 6 parts, 6 parts, Chinese lute.
7. one according to claim 1 treats hypertensive Chinese medicine, it is characterized in that: be made up of Herba Artemisiae Annuae 8 parts, the Fructus Sophorae 8 parts, the Fructus Kochiae 8 parts, Herba Cynomorii 8 parts, Lignum Sappan 8 parts, acorn nut 8 parts, Pulvis Aci 8 parts, bar halberd 8 parts, 8 parts, Chinese lute.
8. one according to claim 1 treats hypertensive Chinese medicine, it is characterized in that: be made up of Herba Artemisiae Annuae 8 parts, the Fructus Sophorae 7 parts, the Fructus Kochiae 6 parts, Herba Cynomorii 5 parts, Lignum Sappan 4 parts, acorn nut 6 parts, Pulvis Aci 3 parts, bar halberd 5 parts, 2 parts, Chinese lute.
9. one according to claim 1 treats hypertensive Chinese medicine, it is characterized in that: be made up of Herba Artemisiae Annuae 2 parts, the Fructus Sophorae 3 parts, the Fructus Kochiae 4 parts, Herba Cynomorii 5 parts, Lignum Sappan 6 parts, acorn nut 7 parts, Pulvis Aci 8 parts, bar halberd 7 parts, 7 parts, Chinese lute.
10. one according to claim 1 treats hypertensive Chinese medicine, it is characterized in that: be made up of Herba Artemisiae Annuae 7 parts, the Fructus Sophorae 7 parts, the Fructus Kochiae 7 parts, Herba Cynomorii 7 parts, Lignum Sappan 7 parts, acorn nut 7 parts, Pulvis Aci 7 parts, bar halberd 7 parts, 7 parts, Chinese lute.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310642357.5A CN104666512A (en) | 2013-11-28 | 2013-11-28 | Traditional Chinese medicine for treating hypertension |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310642357.5A CN104666512A (en) | 2013-11-28 | 2013-11-28 | Traditional Chinese medicine for treating hypertension |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104666512A true CN104666512A (en) | 2015-06-03 |
Family
ID=53302448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310642357.5A Pending CN104666512A (en) | 2013-11-28 | 2013-11-28 | Traditional Chinese medicine for treating hypertension |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104666512A (en) |
-
2013
- 2013-11-28 CN CN201310642357.5A patent/CN104666512A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103920025A (en) | Pharmaceutical composition for treating hypertension and application thereof | |
| CN108743669A (en) | Chinese medicine composition and its preparation method and application for treating goat | |
| Wu et al. | Diverse combination therapies of Chinese Medicine in treating Hypertension | |
| CN103637607A (en) | Hypertensive healthcare drug pillow | |
| CN103417537A (en) | Purpose of dehydrogenation hirsutine | |
| CN103520194A (en) | Novel application of jujuboside A | |
| CN104666512A (en) | Traditional Chinese medicine for treating hypertension | |
| CN103751450A (en) | Composition for treating diabetic nephropathy | |
| CN102895431A (en) | Oral Chinese medicine for treatment of intractable beriberi | |
| CN104888023A (en) | Traditional Chinese medicine preparation for decreasing blood sugar | |
| CN103393737B (en) | Chinese patent pill for improving body immunity | |
| CN103637604B (en) | A kind of hypertensive healthcare drug pillow | |
| CN103405461A (en) | Applications of salicin | |
| CN102526248B (en) | Traditional Chinese medicine prescription capable of curing diabetes wound fester and continuously reducing blood sugar | |
| CN104013631A (en) | New use of cylindrin | |
| CN103432122A (en) | Application of isocorynoxeine in preparation of antihypertensive drugs | |
| CN104055979A (en) | Chinese herb preparation for treating liver and gall damp-heat type chronic pancreatitis | |
| CN103637608B (en) | A kind of hypertensive healthcare drug pillow | |
| CN105311269A (en) | Traditional Chinese medicine preparation capable of reducing blood sugar and preparation method thereof | |
| CN103637606A (en) | Hypertensive healthcare drug pillow | |
| CN105168788A (en) | Traditional Chinese medicinal preparation for treating chronic bronchitis | |
| CN104958625A (en) | Traditional Chinese medicine combination for treating chemical liver injury | |
| CN102697863B (en) | Traditional Chinese medicine composition for treating yin-deficiency monophasic-type high-low-pressure hypertension | |
| CN103405430A (en) | Applications of corynoxine | |
| CN103446172A (en) | Application of fructus camptothecae acuminatae extractive vincoside lactam |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DD01 | Delivery of document by public notice |
Addressee: Wang Rongjia Document name: Notification of Acceptance of Patent Application |
|
| DD01 | Delivery of document by public notice |
Addressee: Wang Qi Document name: Notification of Passing Preliminary Examination of the Application for Invention |
|
| C06 | Publication | ||
| PB01 | Publication | ||
| DD01 | Delivery of document by public notice |
Addressee: Wang Qi Document name: Notification of Publication of the Application for Invention |
|
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150603 |